REVIVA PHARMACEUTICALS HOLDINGS, INC. Cash And Cash Equivalents At Carrying Value

Quick Answer

REVIVA PHARMACEUTICALS HOLDINGS, INC. reported Cash And Cash Equivalents At Carrying Value of $14.44 million for the year ending 2025.

  • REVIVA PHARMACEUTICALS HOLDINGS, INC. showed an increase of +7.1% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from REVIVA PHARMACEUTICALS HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
  • XBRL data for this metric is available from 2018 to 2025 (10 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Historical annual values: Fiscal year 2025: $14.44 million | Fiscal year 2024: $13.48 million | Fiscal year 2023: $23.37 million | Fiscal year 2022: $18.52 million | Fiscal year 2021: $29.69 million | Fiscal year 2020: $8.76 million | Fiscal year 2020: $69.3 thousand | Fiscal year 2019: $193.00 | Fiscal year 2019: $313.0 thousand | Fiscal year 2018: $0.00.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: